Nationwide epidemiology of invasive meningococcal disease in Japan, 2017-2025: implications of post-COVID-19 mobility. [PDF]
Chen Y +9 more
europepmc +1 more source
Breakthrough serogroup Y meningococcal disease in a vaccinated patient with myasthenia gravis receiving ravulizumab: a case report. [PDF]
Strugar SŠ +4 more
europepmc +1 more source
Delayed diagnosis is associated with complications following invasive meningococcal disease in Australian adolescents and young adults. [PDF]
McMillan M +11 more
europepmc +1 more source
Real-world effectiveness and impact of the 4CMenB vaccine against serogroup B invasive meningococcal disease: a systematic review and meta-analysis. [PDF]
Marijic P +12 more
europepmc +1 more source
Invasive Meningococcal Disease in the Post-COVID-19 Era in South America. [PDF]
Sáfadi MAP +7 more
europepmc +1 more source
Invasive Meningococcal Disease in a Patient With Complement 7 Deficiency. [PDF]
Nishioka H, Maegawa K, Hara S.
europepmc +1 more source
Epidemiology of invasive meningococcal disease in the United States: review of recent data and identified risk factors. [PDF]
Presa J +4 more
europepmc +1 more source
Correction to: Risk of Invasive Meningococcal Disease in Children Aged <11 Years in the United States. [PDF]
europepmc +1 more source
Clinically Suspected Invasive Meningococcal Disease Presenting With Purpura Fulminans-Like Rash, Septic Shock, Multiorgan Dysfunction, and Recovery From ARDS in a Previously Healthy Child. [PDF]
Omar S +6 more
europepmc +1 more source
Large outbreak of group B invasive meningococcal disease in young adults in South East England, March 2026. [PDF]
I'Anson J +40 more
europepmc +1 more source

